anti-NYX antibody product blog
Tags: Antibody; Polyclonal Antibody; Nyx; anti-NYX antibody;
The NYX nyx (Catalog #MBS642188) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The NYX, NT (NYX, CLRP, Nyctalopin) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s NYX can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in Western Blot, ELISA
Dilution: ELISA: 1:1,000
Western Blot: 1:100-500. Researchers should empirically determine the suitability of the NYX nyx for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The NYX nyx product has the following accession number(s) (GI #12007646) (NCBI Accession #NP_072089.1) (Uniprot Accession #Q9GZU5). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the NYX, NT (NYX, CLRP, Nyctalopin) with the following immunoassay(s):
Western Blot (WB) (Western blot analysis of NYX Antibody (N-term) in HL-60 cell line lysates (35ug/lane). NYX (arrow) was detected using the purified Pab.)
The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB. [provided by RefSeq].
Immunogen: NYX antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59~89 amino acids from the N-terminal region of human NYX. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NYX are readily searchable from our website. Different antibodies against the same target such as NYX may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. NYX also interacts with the following gene(s): CACNA1F, CNGB3, GRM6, TRPM1. Brain Diseases, Congenital Abnormalities, Eye Diseases, NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A, Nerve Degeneration, Nervous System Diseases, Neurodegenerative Diseases are some of the diseases may be linked to NYX, NT (NYX, CLRP, Nyctalopin).